ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

"Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"

Authors

Ms. Kuchekar S.D , Ms. Bhaldar F.M , Ms. Jagtap S.S , Ms. Mohire V.D , Ms. Barsing A.S

Keywords

4D printing, smart materials, shape memory polymers, hydrogels, drug delivery, bioprinting, adaptive structures, tissue engineering, self-assembly.

Abstract

4D printing (4DP) is an innovative advancement of 3D printing that adds a time-dependent functionality to printed objects. Introduced in 2013, 4DP enables the creation of structures that can transform their shape or behavior when exposed to external stimuli such as heat, light, pH, moisture, or magnetic fields. This is achieved by incorporating smart materials like Shape Memory Polymers (SMPs) and hydrogels into the printing process. SMPs allow objects to return to a pre-defined shape in response to environmental changes, while hydrogels—responsive to temperature, water, or light—are especially useful in biomedical applications like controlled drug delivery.The roots of additive manufacturing trace back to Chuck Hull’s invention of stereolithography (SLA) in 1986. Since then, the field has evolved significantly, and 4DP marks a transformative leap. It has found applications in diverse sectors such as aerospace (deployable satellites, morphing wings), biomedicine (self-expanding stents, personalized implants), pharmaceuticals (targeted drug release), soft robotics, and tissue engineering. In tissue engineering, for instance, 4DP is used to develop scaffolds that adapt to the body's conditions, aiding in regeneration. Technologies like machine learning (ML), finite element analysis (FEA), and computer-aided drug design (CADD) are enhancing 4DP through smarter modeling and predictive design. 4D bioprinting, an extension of this concept, introduces responsiveness into biological structures, improving therapeutic precision and customization. Despite its vast potential, 4DP still faces challenges including limited material availability, slow response times, and the complexity of integrating multiple materials. Specialized software and hardware are also required. However, with ongoing research and innovation, the technology holds promising future applications in space manufacturing, wound care, and even 5D/6D printing. With the global market expected to grow from USD 207.4 million in 2024 to over USD 4.44 billion by 2034, 4DP is poised to revolutionize adaptive and intelligent manufacturing.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJRTI — journal style
""Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 12, page no.a649-a660, December-2025, Available :https://ijrti.org/papers/IJRTI2512082.pdf
APA — 7th edition
S.D, K., F.M, B., S.S, J., V.D, M., & A.S, B. (2025). "Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing". International Journal for Research Trends and Innovation, 10(12), a649-a660. https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082
MLA — 9th edition
S.D, Kuchekar, et al. ""Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"." International Journal for Research Trends and Innovation, vol. 10, no. 12, 2025, pp. a649-a660, https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082.
Chicago — 17th, bibliography
S.D, Kuchekar, et al. ""Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"." International Journal for Research Trends and Innovation 10, no. 12 (2025): a649-a660. https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082.
Harvard — author–date
S.D, K. et al. (2025) '"Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"', International Journal for Research Trends and Innovation, 10(12), pp. a649-a660. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082
IEEE — numbered reference
K. S.D, B. F.M, J. S.S, M. V.D and B. A.S, ""Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"," IJRTI, vol. 10, no. 12, pp. a649-a660, Dec. 2025.
Vancouver — biomedical
S.D K, F.M B, S.S J, V.D M, A.S B. "Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing". IJRTI. 2025 Dec;10(12):a649-a660.
AMA — 11th edition
S.D K, F.M B, S.S J, V.D M, A.S B. "Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing". IJRTI. 2025;10(12):a649-a660. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2512082, author = {Kuchekar S.D and Bhaldar F.M and Jagtap S.S and Mohire V.D and Barsing A.S}, title = {"Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing"}, journal = {International Journal for Research Trends and Innovation}, volume = {10}, number = {12}, pages = {a649-a660}, year = {2025}, month = {December}, issn = {2456-3315}, url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082} }
RIS — EndNote, RefWorks
TY - JOUR AU - S.D, Kuchekar AU - F.M, Bhaldar AU - S.S, Jagtap AU - V.D, Mohire AU - A.S, Barsing TI - "Stimuli-Responsive Pharmaceuticals: The Next Dimension with 4D Printing" T2 - International Journal for Research Trends and Innovation JA - IJRTI VL - 10 IS - 12 PY - 2025 SN - 2456-3315 UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2512082 SP - a649-a660 ER -

Issue

Volume 10 Issue 12, December-2025
Pages : a649-a660

Other Publication Details

Paper Reg. ID IJRTI_206560
Published Paper ID IJRTI2512082
Downloads 205,627
Research Area Engineering
Country -, -, India
Published December 2025

About Publisher

International Journal for Research Trends and Innovation Published by IJRTI (JW Publication)
2456-3315 ISSN
10.57 Impact Factor
2016 ESTD Year
Open Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹599
Publish in a UGC CARE Approved Journal | Low Cost ₹599 Indian Author | 🌐 $45 USD International
CrossRef/DataCite DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →